Want to see IPX full AI Analyst Report?
Top Page
Iperionx Ltd. ADR
(NASDAQ:IPX)
Select Model
Select Model
Rating:42Neutral
Price Target:
$12.00
▼(-46.67% Downside)
Action:Reiterated
Date:09/30/26
IPX scores low primarily due to pre-revenue fundamentals with widening losses and accelerating cash burn, which increase execution and financing/dilution risk despite a relatively low-debt balance sheet. Technicals also weigh on the score as the stock is in a clear downtrend with weak momentum. Valuation provides limited support because the negative P/E reflects ongoing losses and there is no dividend yield data.
Positive Factors
Low financial leverage
Modest debt relative to equity limits balance-sheet solvency pressure and reduces the burden of interest and refinancing obligations. This gives IperionX greater financial flexibility than a heavily leveraged early-stage company while it works toward commercial scale.
Negative Factors
No reported revenue
Persistent zero revenue indicates that the business has not yet demonstrated commercial monetization across the reported period. This leaves future funding and shareholder returns dependent on successful execution of development and production plans rather than an established operating revenue base.
Read all positive and negative factors
Positive Factors
Negative Factors
Low financial leverage
Modest debt relative to equity limits balance-sheet solvency pressure and reduces the burden of interest and refinancing obligations. This gives IperionX greater financial flexibility than a heavily leveraged early-stage company while it works toward commercial scale.
Read all positive factors
Iperionx Ltd. ADR (IPX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$452.08M
Dividend YieldN/A
Average Volume (3M)354.50K
Price to Earnings (P/E)―
Beta (1Y)2.13
Revenue GrowthN/A
EPS Growth-65.78%
CountryUS
Employees28
SectorBasic Materials
Sector Strength58
IndustryOther Precious Metals
Share Statistics
EPS (TTM)-19.90
Shares Outstanding36,224,020
10 Day Avg. Volume345,205
30 Day Avg. Volume354,501
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.13
Price to Sales (P/S)0.00
P/FCF Ratio-1.58
Enterprise Value/Market Cap2.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-224.23
Enterprise Value/Ebitda-14.92
Forecast
1Y Price Target
$37.67Price Target Upside67.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.18
Revenue Forecast (FY)$21.54M
Iperionx Ltd. ADR Business Overview & Revenue Model
Company Description
IperionX Limited primarily focuses on discovering and developing mineral resource sites. The company's geological surveys seek out valuable deposits, specifically targeting epithermal and replacement-style precious and base metals, alongside titan...
Iperionx Ltd. ADR Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
63
Positive
Cash Flow
18
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -4.37M | -2.27M | -648.22K | -634.11K | -152.90K |
| EBITDA | -65.65M | -37.00M | -21.97M | -16.86M | -21.64M |
| Net Income | -67.07M | -35.35M | -22.23M | -17.44M | -21.52M |
Balance Sheet | |||||
| Total Assets | 105.75M | 105.03M | 55.44M | 22.80M | 9.91M |
| Cash, Cash Equivalents and Short-Term Investments | 35.24M | 54.81M | 33.16M | 11.94M | 5.67M |
| Total Debt | 4.16M | 3.93M | 1.48M | 969.34K | 537.44K |
| Total Liabilities | 17.45M | 12.59M | 4.10M | 2.24M | 2.49M |
| Stockholders Equity | 88.30M | 92.44M | 51.34M | 20.56M | 7.42M |
Cash Flow | |||||
| Free Cash Flow | -63.02M | -39.41M | -26.68M | -18.57M | -14.06M |
| Operating Cash Flow | -45.16M | -21.80M | -18.68M | -15.86M | -12.13M |
| Investing Cash Flow | -18.64M | -24.28M | -6.53M | -5.71M | -3.07M |
| Financing Cash Flow | 43.37M | 67.99M | 46.59M | 27.89M | 19.39M |
Iperionx Ltd. ADR Technical Analysis
Negative
22.50
Price Trends
18.77
Negative
23.03
Negative
31.08
Negative
Market Momentum
-1.78
Positive
28.63
Positive
6.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Negative. The current price of 22.5 is above the 20-day moving average (MA) of 15.34, above the 50-day MA of 18.77, and below the 200-day MA of 31.08, indicating a bearish trend. The MACD of -1.78 indicates Positive momentum. The RSI at 28.63 is Positive, neither overbought nor oversold. The STOCH value of 6.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IPX.
Iperionx Ltd. ADR Risk Analysis
Iperionx Ltd. ADR disclosed 51 risk factors in its most recent earnings report. Iperionx Ltd. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Iperionx Ltd. ADR Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $4.61B | 50.94 | 9.41% | 0.26% | 21.56% | 454.16% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | $6.82B | -112.05 | -2.66% | ― | 71.92% | 44.39% | |
48 Neutral | $3.50B | -3.88 | -23.45% | ― | ― | -270.60% | |
47 Neutral | $193.90M | -2.35 | -64.63% | ― | 406.77% | 3.36% | |
43 Neutral | $430.26M | -5.19 | -13.82% | ― | ― | 99.00% | |
42 Neutral | $452.08M | -6.26 | -67.95% | ― | ― | -65.78% |
* Basic Materials Sector Average
IPX
Iperionx Ltd. ADR
12.44
-37.23
-74.95%
MTRN
Materion
221.06
87.12
65.04%
NB
NioCorp Developments
2.95
-5.31
-64.29%
ABAT
American Battery Technology
1.35
-4.63
-77.42%
MP
MP Materials
38.30
-32.51
-45.91%
USAR
USA Rare Earth
9.33
-14.24
-60.42%
Iperionx Ltd. ADR Corporate Events
IperionX Sets November 25 AGM to Vote on Board Slate and Director Equity
Oct 15, 2026
On October 15, 2026, IperionX Limited filed a Form 6-K announcing its annual general meeting of shareholders, scheduled for November 25, 2026, in Sydney, Australia. The meeting will consider the company’s annual report for the year ended Jun...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.